Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.

× No keyword cloud information.

36 in total

Review 1. Antibacterial drugs today. I.

Authors: A P Ball; J A Gray; J M Murdoch
Journal: Drugs Date: 1975 Impact factor: 9.546

Review 2. Synergy of trimethoprim-sulfamethoxazole.

Authors: S R Bushby
Journal: Can Med Assoc J Date: 1975-06-14 Impact factor: 8.262

3. Prediction of resistance development against drug combinations by collateral responses to component drugs.

Authors: Christian Munck; Heidi K Gumpert; Annika I Nilsson Wallin; Harris H Wang; Morten O A Sommer
Journal: Sci Transl Med Date: 2014-11-12 Impact factor: 17.956

4. Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates.

Authors: Raquel Barbolla; Mariana Catalano; Betina E Orman; Angela Famiglietti; Carlos Vay; Jorgelina Smayevsky; Daniela Centrón; Silvia A Piñeiro
Journal: Antimicrob Agents Chemother Date: 2004-02 Impact factor: 5.191

5. Trimethoprim-sulfamethoxazole: A reappraisal.

Authors: F O'Grady
Journal: Can Med Assoc J Date: 1975-06-14 Impact factor: 8.262

6. Tuberculosis and trimethoprim-sulfamethoxazole.

Authors: Pierre Forgacs; Nancy L Wengenack; Leslie Hall; Sarah K Zimmerman; Mark L Silverman; Glenn D Roberts
Journal: Antimicrob Agents Chemother Date: 2009-06-29 Impact factor: 5.191

Review 7. Trimethoprim: a review of its antibacterial activity, pharmacokinetics and therapeutic use in urinary tract infections.

Authors: R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1982-06 Impact factor: 9.546

8. Pharmacokinetics of sulfadiazine and trimethoprim in man.

Authors: F Andreasen; L Elsborg; S Husted; O Thomsen
Journal: Eur J Clin Pharmacol Date: 1978-11-09 Impact factor: 2.953

9. Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.

Authors: H H Gadebusch; D L Shungu; E Weinberg; S K Chung
Journal: Infection Date: 1982-01 Impact factor: 3.553

10. Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors: R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal: Antimicrob Agents Chemother Date: 1981-01 Impact factor: 5.191